We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont Gets Approval for Lumisena Fungicide Seed Treatment
Read MoreHide Full Article
DuPont (DD - Free Report) recently secured registration approval from the Environmental Protection Agency for the Lumisena fungicide seed treatment. Lumisena fungicide seed treatment is the latest addition to the DuPont seed applied technology portfolio.
Lumisena fungicide seed treatment improves crop establishment and provides uniformity by controlling Phytophthora in soybeans and downy mildew in sunflower crops. Lumisena fungicide seed treatment contains an ingredient called Oxathiapiprolin, which controls pathogens during various stages of their life cycle as a result providing healthier plants that emerge quickly and develop strong root masses.
While the trials were carried out, the soybean seed that was protected with Lumisena fungicide seed treatment, had 32% less Phytophthora sojae incidence than untreated seed. Additionally, university research trials demonstrated that soybeans treated with the active ingredient in Lumisena fungicide seed treatment provided outstanding protection against Phytophthora compared with traditional seed treatment fungicides.
For sunflowers, DuPont trials exhibited seed treated with Lumisena fungicide seed treatment had 76% to 96% less downy mildew compared to untreated seed and 20% to 41% less downy mildew compared to the traditional fungicide seed treatments. Further, the university trials showed that sunflower seed treated with the active ingredient in Lumisena fungicide seed treatment produced plants with considerably less downy mildew compared with existing fungicide seed treatments.
DuPont has outperformed the Zacks categorized Chemical industry in the past three months. The company’s shares have gained around 12% in this period, compared with a 6.7% gain recorded by the industry.
DuPont is well poised to gain from its aggressive cost-cutting measures and new product launches. The company has a positive record of earnings surprises in recent quarters, aided by its cost management actions. The company remains on track to deliver net cost reductions of $730 million in 2016. It has raised its adjusted earnings guidance for 2016, factoring in the benefits of its cost-saving initiatives.
Moreover, DuPont is moving forward with its planned mega-merger with The Dow Chemical Company (DOW - Free Report) , which is expected to create significant synergies.
DuPont is a Zacks Rank #3 (Hold) stock.
Stocks to Consider
Some better-ranked companies in the chemical space include The Chemours Company (CC - Free Report) and FMC Corp. (FMC - Free Report) , both sporting a Zacks Rank #1 (Strong Buy).
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time? Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
DuPont Gets Approval for Lumisena Fungicide Seed Treatment
DuPont (DD - Free Report) recently secured registration approval from the Environmental Protection Agency for the Lumisena fungicide seed treatment. Lumisena fungicide seed treatment is the latest addition to the DuPont seed applied technology portfolio.
Lumisena fungicide seed treatment improves crop establishment and provides uniformity by controlling Phytophthora in soybeans and downy mildew in sunflower crops. Lumisena fungicide seed treatment contains an ingredient called Oxathiapiprolin, which controls pathogens during various stages of their life cycle as a result providing healthier plants that emerge quickly and develop strong root masses.
While the trials were carried out, the soybean seed that was protected with Lumisena fungicide seed treatment, had 32% less Phytophthora sojae incidence than untreated seed. Additionally, university research trials demonstrated that soybeans treated with the active ingredient in Lumisena fungicide seed treatment provided outstanding protection against Phytophthora compared with traditional seed treatment fungicides.
For sunflowers, DuPont trials exhibited seed treated with Lumisena fungicide seed treatment had 76% to 96% less downy mildew compared to untreated seed and 20% to 41% less downy mildew compared to the traditional fungicide seed treatments. Further, the university trials showed that sunflower seed treated with the active ingredient in Lumisena fungicide seed treatment produced plants with considerably less downy mildew compared with existing fungicide seed treatments.
DuPont has outperformed the Zacks categorized Chemical industry in the past three months. The company’s shares have gained around 12% in this period, compared with a 6.7% gain recorded by the industry.
DuPont is well poised to gain from its aggressive cost-cutting measures and new product launches. The company has a positive record of earnings surprises in recent quarters, aided by its cost management actions. The company remains on track to deliver net cost reductions of $730 million in 2016. It has raised its adjusted earnings guidance for 2016, factoring in the benefits of its cost-saving initiatives.
Moreover, DuPont is moving forward with its planned mega-merger with The Dow Chemical Company (DOW - Free Report) , which is expected to create significant synergies.
DuPont is a Zacks Rank #3 (Hold) stock.
Stocks to Consider
Some better-ranked companies in the chemical space include The Chemours Company (CC - Free Report) and FMC Corp. (FMC - Free Report) , both sporting a Zacks Rank #1 (Strong Buy).
Chemours has an expected long-term growth of 15.5%. You can the complete list of today’s Zacks #1 Rank stocks here.
FMC has an expected long-term growth of 10.88%.
DU PONT (EI) DE Price
DU PONT (EI) DE Price | DU PONT (EI) DE Quote
Zacks’ Best Private Investment Ideas
In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time? Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>